Wolfgang Baiker, M.D., Ph.D., M.B.A., is the President and Chief Executive Officer (CEO) of BI USA and the US Country Managing Director. Dr. Baiker leads the team that ensures the company’s success in the US for all of BI’s businesses, including Human Pharma, Animal Health and Bio Manufacturing.

Prior to this position, Dr. Baiker served as Senior Vice President, Human Pharma Supply & Global Quality, as well as Head of the Biopharma Business Unit. He joined Boehringer Ingelheim in 1989 as Section Head for Clinical Development in Biberach, Germany.

Since then, Dr. Baiker has held a number of senior leadership roles across several critical business functions, including Head of International Project Management; Head of Global Development; Member of the Board of Managing Directors (BMD) responsible for Corporate Board Division Biopharmaceuticals and Operations; and currently, as a key member of the Human Pharma Executive Committee.

Dr. Baiker completed his medical studies and doctorate at the Universities of Bochum, Berlin, Ulm, Munich and Sheffield and received his MBA from Pace University in New York.